Evidence map›Paper›PMID 32854691›Full record

ArticleBMC palliative care2020

Role of norms in variation in cancer centers' end-of-life quality: qualitative case study protocol.

Kristin E Knutzen, Karen E Schifferdecker, Genevra F Murray, Shama S Alam, Gabriel A Brooks, Nirav S Kapadia, Rebecca Butcher, Amber E Barnato

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC palliative care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03780816 (Variation in Cancer Centers' End-of-Life Quality), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03780816 completednot on this map

Variation in Cancer Centers' End-of-Life Quality

TypeobservationalSponsorDartmouth-Hitchcock Medical CenterRan2019 to 2021Enrolled473ConditionsAdvanced CancerArmsObservation of provider-patient interactions and interviews
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Kristin E KnutzenDepartment of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Karen E SchifferdeckerThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
Genevra F MurrayDepartment of General Internal Medicine, Boston Medical Center, Boston, MA, USA.
Shama S AlamEvidera, Pharmaceutical Product Development, Bethesda, MD, USA.
Gabriel A BrooksThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
Nirav S KapadiaThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
Rebecca ButcherThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
Amber E BarnatoThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA. Amber.Barnato@Dartmouth.edu.ORCID http://orcid.org/0000-0003-1080-6270
Dartmouth College · USBoston Medical Center · USEmory University · USPharmaceutical Product Development (United States) · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Training in Health Services Research for Vulnerable PopulationsT32HS022242 · AHRQ · BOSTON MEDICAL CENTER · PI LAROCHELLE, MARC · 2013 to 2024
$4.1M
AHRQ HHS T32 HS022242American Cancer Society RSG-18-017-01-CPHPSNCI NIH HHS P30 CA023108
6 · The paper itself

Abstract

backgroundA critical barrier to improving the quality of end-of-life (EOL) cancer care is our lack of understanding of the mechanisms underlying variation in EOL treatment intensity. This study aims to fill this gap by identifying 1) organizational and provider practice norms at major US cancer centers, and 2) how these norms influence provider decision making heuristics and patient expectations for EOL care, particularly for minority patients with advanced cancer.

methodsThis is a multi-center, qualitative case study at six National Comprehensive Cancer Network (NCCN) and National Cancer Institute (NCI) Comprehensive Cancer Centers. We will theoretically sample centers based upon National Quality Forum (NQF) endorsed EOL quality metrics and demographics to ensure heterogeneity in EOL intensity and region. A multidisciplinary team of clinician and non-clinician researchers will conduct direct observations, semi-structured interviews, and artifact collection. Participants will include: 1) cancer center and clinical service line administrators; 2) providers from medical, surgical, and radiation oncology; palliative or supportive care; intensive care; hospital medicine; and emergency medicine who see patients with cancer and have high clinical practice volume or high local influence (provider interviews and observations); and 3) adult patients with metastatic solid tumors and whom the provider would not be surprised if they died in the next 12 months and their caregivers (patient and caregiver interviews). Leadership interviews will probe about EOL institutional norms and organization. We will observe inpatient and outpatient care for two weeks. Provider interviews will use vignettes to probe explicit and implicit motivations for treatment choices. Semi-structured interviews with patients near EOL, or their family members and caregivers will explore past, current, and future decisions related to their cancer care. We will import transcribed field notes and interviews into Dedoose software for qualitative data management and analysis, and we will develop and apply a deductive and inductive codebook to the data. DISCUSSION: This study aims to improve our understanding of organizational and provider practice norms pertinent to EOL care in U.S. cancer centers. This research will ultimately be used to inform a provider-oriented intervention to improve EOL care for racial and ethnic minority patients with advanced cancer.

trial registrationClinicaltrials.gov ; NCT03780816 ; December 19, 2018.

Indexed as

Cancer Care FacilitiesQuality of Health CareTerminal CareHumansInterviews as TopicQualitative ResearchResearch DesignCancerEnd-of-lifeHeuristicsMinority healthNorms

Identifiers

PMID32854691
PMCPMC7453548
OpenAlexW3082060373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.